Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes an efficient method of differentiating hiPSCs into eye field clusters and generating neuro-retinal organoids using simplified culture conditions involving both adherent and suspension culture systems. Other ocular cell types, such as the RPE and corneal epithelium, can also be isolated from mature eye fields in retinal cultures.

Abstract

Pluripotent stem cells can generate complex tissue organoids that are useful for in vitro disease modeling studies and for developing regenerative therapies. This protocol describes a simpler, robust, and stepwise method of generating retinal organoids in a hybrid culture system consisting of adherent monolayer cultures during the first 4 weeks of retinal differentiation till the emergence of distinct, self-organized eye field primordial clusters (EFPs). Further, the doughnut-shaped, circular, and translucent neuro-retinal islands within each EFP are manually picked and cultured under suspension using non-adherent culture dishes in a retinal differentiation medium for 1-2 weeks to generate multilayered 3D optic cups (OC-1M). These immature retinal organoids contain PAX6+ and ChX10+ proliferating, multipotent retinal precursors. The precursor cells are linearly self-assembled within the organoids and appear as distinct radial striations. At 4 weeks after suspension culture, the retinal progenitors undergo post-mitotic arrest and lineage differentiation to form mature retinal organoids (OC-2M). The photoreceptor lineage committed precursors develop within the outermost layers of retinal organoids. These CRX+ and RCVRN+ photoreceptor cells morphologically mature to display inner segment-like extensions. This method can be adopted for generating retinal organoids using human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). All steps and procedures are clearly explained and demonstrated to ensure replicability and for wider applications in basic science and translational research.

Introduction

The retina is a light-sensitive tissue present at the back of the vertebrate eye that converts light signals into nerve impulses by a biochemical phenomenon known as the photo-transduction pathway. The initial nerve impulses generated in the photoreceptor cells of the retina get transduced to other retinal interneurons and retinal ganglion cells (RGCs) and reach the visual cortex of the brain, which helps in image perception and visual response.

According to the World Health Organization (WHO), an estimated 1.5 million children are blind, of which 1 million are in Asia. Inherited Retinal Dystrophy (IRD) is a major blinding disease that affe....

Protocol

All experiments involving hiPSCs were carried out aseptically, in adherence to the standard laboratory practices, ethical and biosafety guidelines, and with the approvals of regulatory bodies such as the Institutional Ethics Committee (IEC), Institutional Committee for Stem Cell Research (IC-SCR), and Institutional Bio-Safety Committee (IBSC).

1. Preparation of iPSC culture and retinal differentiation medium and reagents

  1. iPSC culture and maintenance medium
      .......

Representative Results

Differentiation of hiPSCs into eye lineages is achieved by culturing the cells in different cocktails of culture medium containing supplements and growth factors in sequential steps at different time points, as described in Figure 1. The hiPSC cultures are maintained in Essential 8 medium, the pluripotent stem cell maintenance medium. Once they reach 70%-80% confluency (Figure 2A), the medium is replaced with Differentiation Induction Medium (DIM) on day 0 (refe.......

Discussion

hiPSCs are a powerful tool to study organ and tissue development in vitro. Recapitulating the disease phenotype by differentiating healthy versus disease-specific hiPSCs toward the retinal lineage can help in gaining newer insights into the pathophysiology of different forms of inherited retinal dystrophies. Several protocols have been described and adopted for the in vitro differentiation of PSCs into retinal cell types. Most of them involve the use of culture medium containing complex cocktails of rec.......

Acknowledgements

The authors acknowledge the scientific and technical support from Dr. Chitra Kannabiran, Geneticist; Dr. Subhadra Jalali, Retinal Consultant; Dr. Milind Naik, Oculoplastic Surgeon; and Dr. Swathi Kaliki, Ocular Oncologist at the LV Prasad Eye Institute, Hyderabad toward the generation of normal and patient-specific iPSC lines. The authors acknowledge the R&D grants from the Science and Engineering Research Board, Department of Science and Technology (IM), (SB/SO/HS/177/2013), Department of Biotechnology (IM), (BT/PR32404/MED/30/2136/2019) ,and Senior Research Fellowships from ICMR (S.M., D.P.), UGC (T.A.), and CSIR (V.K.P.), Government of India.

....

Materials

NameCompanyCatalog NumberComments
0.22 µm Syringe filtersTPP99722 
15 mL centrifuge tubeTPP91015
50 mL centrifuge tubeTPP91050
6 well platesTPP92006
Anti-Chx10 Antibody; Mouse monoclonalSanta CruzSC3655191:50 dilution
Anti-CRX antibody; Rabbit monoclonalAbcamab1406031:300 dilution
Anti-MiTF antibody, Mouse monoclonalAbcamab32011:250 dilution
Anti-Recoverin Antibody; Rabbit polyclonal     MilliporeAB55851:300 dilution
B-27 Supplement (50x), serum freeThermo Fisher17504044
Basic Fibroblast growth factor (bFGF)Sigma AldrichF0291
Centrifuge 5810REppendorf
Coplin Jar (50 mL)Tarson
Corning Matrigel hESC-Qualified MatrixCorning354277
CryoTubesThermo FisherV7884
DMEM/F-12, GlutaMAX supplement (basal medium)Thermo Fisher10565-018
DreamTaq DNA polymeraseThermo FisherEP0709
Dulbeco’s Phosphate Buffered SalineThermo Fisher14190144
Essential 8 medium kitThermo FisherA1517001
Ethylene diamine tetraaceticacid disodium salt dihydrate (EDTA)Sigma AldrichE5134
Falcon Not TC-treated Treated Petri Dish, 60 mm Corning351007
Fetal Bovine Serum, qualified, United States Gibco26140079
GelDocXR+ with Image lab softwareBIO-RADAgarose Gel documentation system 
GlutaMAX SupplementThermo Fisher35050061
Goat anti-Mouse IgG (H+L), Alexa Fluor 488InvitrogenA110011:300 dilution
Goat anti-Mouse IgG (H+L), Alexa Fluor 546InvitrogenA110301:300 dilution
Goat anti-Rabbit IgG (H+L), Alexa Fluo 546InvitrogenA110351:300 dilution
Goat anti-Rabbit- IgG (H+L), Alexa Fluor 488InvitrogenA110081:300 dilution
HistoCore MULTICUTLeicaFor sectioning
KnockOut Serum ReplacementThermo Fisher10828028
L-Acsorbic acidSigma AldrichA92902
MEM Non-Essential Amino Acids Solution (100x)Thermo Fisher11140-050
N2 supplement (100x)Thermo Fisher17502048
NanoDrop 2000Thermo FisherTo quantify RNA
ParaformaldehydeQualigens23995
Pasteur Pipets, 9 inch, Non-Sterile, UnpluggedCorning7095D-9
Penicillin-Streptomycin Thermo Fisher15140-122
Recombinant Anti-Otx2 antibody , Rabbit monoclonalAbcamab1839511:300 dilution
Recombinant Anti-PAX6 antibody; Rabbit MonoclonalAbcamab1950451:300 dilution
Recombinant Anti-RPE65 antibody, Rabbit MonoclonalAbcamab2317821:300 dilution
Recombinant Human Noggin ProteinR&D Systems6057-NG
SeaKem LE AgaroseLonza50004
Serological pipettes 10 mLTPP94010
Serological pipettes 5 mLTPP94005
Sodium ChlorideSigma AldrichS7653
Sodium Citrate Tribasic dihydrateSigma AldrichS4641
Starfrost (silane coated) microscopic slidesKnittel
SuperScript III First-Strand Synthesis SystemThermo Fisher18080051
SuperScript III First-Strand Synthesis System for RT-PCRInvitrogen18080051
Triton X-100Sigma AldrichT8787
TRIzol ReagentInvitrogen15596026
UltraPure 0.5 M EDTA, pH 8.0Thermo Fisher15575020
VECTASHIELD Antifade Mounting Medium with DAPI Vector laboratoriesH-1200 
VitronectinThermo FisherA27940
Y-27632 dihydrochloride (Rho-kinase inhibitor)Sigma AldrichY0503
Zeiss LSM 880ZeissConfocal microscope

References

  1. Dandona, R., et al. Moderate visual impairment in India: the Andhra Pradesh Eye Disease Study. British Journal of Ophthalmology. 86 (4), 373-377 (2002).
  2. Hartong, D. T., Berson, E. L., Dryja, T. P. Retinitis pigmentosa. Lanc....

Explore More Articles

Retinal OrganoidsHuman Induced Pluripotent Stem CellsRetinal DegenerationRetinal Pigment EpitheliumIn Vitro ModelsCell based TherapiesEye DevelopmentInherited Retinal DiseasesDifferentiationAdherent CultureSuspension CultureRetinal CupsSpatial PositioningMorphological FeaturesCell DissociationIPSC CultureDifferentiation Induction MediumBFGFNoggin

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved